KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Preferred Stock Liabilities (2023 - 2025)

Evolent Health has reported Preferred Stock Liabilities over the past 4 years, most recently at $228.8 million for Q2 2025.

  • Quarterly results put Preferred Stock Liabilities at $228.8 million for Q2 2025, up 24.21% from a year ago — trailing twelve months through Jun 2025 was $228.8 million (up 24.21% YoY), and the annual figure for FY2024 was $190.2 million, up 6.58%.
  • Preferred Stock Liabilities for Q2 2025 was $228.8 million at Evolent Health, up from $193.2 million in the prior quarter.
  • Over the last five years, Preferred Stock Liabilities for EVH hit a ceiling of $228.8 million in Q2 2025 and a floor of $170.6 million in Q1 2023.
  • Median Preferred Stock Liabilities over the past 3 years was $182.8 million (2024), compared with a mean of $186.2 million.
  • Biggest five-year swings in Preferred Stock Liabilities: grew 6.25% in 2024 and later grew 24.21% in 2025.
  • Evolent Health's Preferred Stock Liabilities stood at $178.4 million in 2023, then grew by 6.58% to $190.2 million in 2024, then rose by 20.31% to $228.8 million in 2025.
  • The last three reported values for Preferred Stock Liabilities were $228.8 million (Q2 2025), $193.2 million (Q1 2025), and $190.2 million (Q4 2024) per Business Quant data.